<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.1?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Database (Oxford)</journal-id>
    <journal-id journal-id-type="iso-abbrev">Database (Oxford)</journal-id>
    <journal-id journal-id-type="publisher-id">databa</journal-id>
    <journal-title-group>
      <journal-title>Database: The Journal of Biological Databases and Curation</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1758-0463</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">6859256</article-id>
    <article-id pub-id-type="doi">10.1093/database/baz115</article-id>
    <article-id pub-id-type="publisher-id">baz115</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Original Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Identification of tRNA-derived ncRNAs in TCGA and NCI-60 panel cell lines and development of the public database tRFexplorer</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>La Ferlita</surname>
          <given-names>Alessandro</given-names>
        </name>
        <xref ref-type="aff" rid="aff1">1</xref>
        <xref ref-type="aff" rid="aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Alaimo</surname>
          <given-names>Salvatore</given-names>
        </name>
        <xref ref-type="aff" rid="aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Veneziano</surname>
          <given-names>Dario</given-names>
        </name>
        <xref ref-type="aff" rid="aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Nigita</surname>
          <given-names>Giovanni</given-names>
        </name>
        <xref ref-type="aff" rid="aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Balatti</surname>
          <given-names>Veronica</given-names>
        </name>
        <xref ref-type="aff" rid="aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Croce</surname>
          <given-names>Carlo M</given-names>
        </name>
        <xref ref-type="aff" rid="aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ferro</surname>
          <given-names>Alfredo</given-names>
        </name>
        <xref ref-type="aff" rid="aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Pulvirenti</surname>
          <given-names>Alfredo</given-names>
        </name>
        <!--<email>apulvirenti@dmi.unict.it</email>-->
        <xref rid="cor1" ref-type="corresp"/>
        <xref ref-type="aff" rid="aff2">2</xref>
      </contrib>
    </contrib-group>
    <aff id="aff1"><label>1</label><institution>Department of Physics and Astronomy</institution>, University of Catania, Catania, <country country="IT">Italy</country></aff>
    <aff id="aff2"><label>2</label><institution>Department of Clinical and Experimental Medicine</institution>, University of Catania, Catania, <country country="IT">Italy</country></aff>
    <aff id="aff3"><label>3</label><institution>Department of Cancer Biology and Genetics</institution>, Comprehensive Cancer Center, The Ohio State University, Columbus, OH</aff>
    <author-notes>
      <corresp id="cor1">Corresponding author: Tel: +390 9 573 83087; Fax:+390 9 533 0094; Email: <email>apulvirenti@dmi.unict.it</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <year>2019</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2019-11-18">
      <day>18</day>
      <month>11</month>
      <year>2019</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>18</day>
      <month>11</month>
      <year>2019</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
    <volume>2019</volume>
    <elocation-id>baz115</elocation-id>
    <history>
      <date date-type="received">
        <day>20</day>
        <month>11</month>
        <year>2018</year>
      </date>
      <date date-type="rev-recd">
        <day>1</day>
        <month>7</month>
        <year>2019</year>
      </date>
      <date date-type="accepted">
        <day>2</day>
        <month>9</month>
        <year>2019</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2019. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2019</copyright-year>
      <license license-type="cc-by" xlink:href="http://creativecommons.org/licenses/by/4.0/">
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="baz115.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>Next-generation sequencing is increasing our understanding and knowledge of non-coding RNAs (ncRNAs), elucidating their roles in molecular mechanisms and processes such as cell growth and development. Within such a class, tRNA-derived ncRNAs have been recently associated with gene expression regulation in cancer progression. In this paper, we characterize, for the first time, tRNA-derived ncRNAs in NCI-60. Furthermore, we assess their expression profile in The Cancer Genome Atlas (TCGA). Our comprehensive analysis allowed us to report 322 distinct tRNA-derived ncRNAs in NCI-60, categorized in tRNA-derived fragments (11 tRF-5s, 55 tRF-3s), tRNA-derived small RNAs (107 tsRNAs) and tRNA 5′ leader RNAs (149 sequences identified). In TCGA, we were able to identify 232 distinct tRNA-derived ncRNAs categorized in 53 tRF-5s, 58 tRF-3s, 63 tsRNAs and 58 5′ leader RNAs. This latter group represents an additional evidence of tRNA-derived ncRNAs originating from the 5′ leader region of precursor tRNA. We developed a public database, tRFexplorer, which provides users with the expression profile of each tRNA-derived ncRNAs in every cell line in NCI-60 as well as for each TCGA tumor type. Moreover, the system allows us to perform differential expression analyses of such fragments in TCGA, as well as correlation analyses of tRNA-derived ncRNAs expression in TCGA and NCI-60 with gene and miRNA expression in TCGA samples, in association with all omics and compound activities data available on CellMiner. Hence, the tool provides an important opportunity to investigate their potential biological roles in absence of any direct experimental evidence.</p>
      <p>Database URL: <ext-link ext-link-type="uri" xlink:href="https://trfexplorer.cloud/">https://trfexplorer.cloud/</ext-link></p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <named-content content-type="funder-name">Italian MIUR ‘PON RI FSE-FESR 2014-2020’</named-content>
        </funding-source>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="13"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec id="sec1">
    <title>Introduction</title>
    <p>With the advent of next-generation sequencing technologies, the number of characterized ncRNA classes in eukaryotic cells has dramatically increased (<xref rid="ref1" ref-type="bibr">1–3)</xref>. Recently, tRNA-derived non-coding RNAs (ncRNAs), a novel heterogeneous class of ncRNAs originating from tRNA processing, have been characterized. Indeed, it has been shown that tRNA-derived ncRNAs are not mere byproducts of random tRNA cleavage, rather they may actively play roles in several biological phenomena, such as ribosome biogenesis, retrotransposition, virus infections, apoptosis and cancer pathogenesis (<xref rid="ref4" ref-type="bibr">4–13)</xref>. Furthermore, some classes of tRNA-derived ncRNAs have been shown to bind AGO and PIWI proteins, potentially acting as post- or pre-transcriptional regulators of gene expression (<xref rid="ref9" ref-type="bibr">9</xref>, <xref rid="ref14" ref-type="bibr">14)</xref>.</p>
    <p>Accumulating evidence also suggests the presence of functional tRNA-derived ncRNAs in human biological fluids, such as urine and serum from cancer patients (<xref rid="ref15" ref-type="bibr">15–19)</xref>.</p>
    <p>tRNA biogenesis begins with the transcription of tRNA genes by RNA polymerase III leading to ‘precursor tRNA’ (pre-tRNA). Such molecules undergo a maturation process inside the nucleus, where 5′ leader and 3′ trailer sequences are cleaved by ribonuclease P (RNase P) and ribonuclease Z (RNase Z), respectively (<xref rid="ref15" ref-type="bibr">15</xref>, <xref rid="ref20" ref-type="bibr">20–25)</xref>. In the last few years, several kinds of tRNA-derived ncRNAs have been discovered. However, a unique classification is still missing. A common grouping of such molecules is based on the location they originate from within the tRNA gene. tRNA-derived ncRNAs can, therefore, be divided into two main classes: (i) tsRNAs, which derive from pre-tRNA and (ii) stress-induced tRNA fragments (tiRNAs), together with tRFs, which derive from mature tRNA (<xref rid="ref13" ref-type="bibr">13)</xref>.</p>
    <p>tsRNA are produced inside the nucleus and result from the cleavage of the pre-tRNAs 3′ trailer sequence by RNases Z. They usually begin after the 3′-end of mature tRNAs and are characterized by a polyuracil sequence at their 3′-ends (<xref rid="ref13" ref-type="bibr">13)</xref>.</p>
    <p>tiRNAs, which have a length of ~28–36 nt, are produced in the cytoplasm via specific cleavage of the anticodon loop of mature tRNAs by Rny1p and angiogenin (ANG) in yeast and mammalians cells, respectively (<xref rid="ref15" ref-type="bibr">15</xref>, <xref rid="ref26" ref-type="bibr">26</xref>, <xref rid="ref27" ref-type="bibr">27)</xref>. This class is comprised of 5’-tiRNA and 3’-tiRNA, in reference to the 5′ or 3′ half of the mature tRNA they derive from, respectively (<xref rid="ref15" ref-type="bibr">15)</xref>.</p>
    <p>tRFs, ranging from 14 to 30 nt in length, are derived from mature tRNA (<xref rid="ref15" ref-type="bibr">15</xref>, <xref rid="ref23" ref-type="bibr">23</xref>, <xref rid="ref28" ref-type="bibr">28)</xref>. Three types of tRFs have been discovered to date: (i) tRF-5s; (ii) tRF-3s; and (iii) i-tRFs (<xref rid="ref29" ref-type="bibr">29</xref>, <xref rid="ref30" ref-type="bibr">30)</xref>. tRF-5s are generated in the cytoplasm by Dicer-mediated cleavage of the mature tRNA D-loop (<xref rid="ref29" ref-type="bibr">29</xref>, <xref rid="ref31" ref-type="bibr">31)</xref>. tRF-3s are produced in the cytoplasm via cleavage of the T-loop in mature tRNAs operated by Dicer, ANG and other members of the RNase A superfamily. They are fragments originating from mature tRNA 3′-ends, and include the final CCA sequence (<xref rid="ref28" ref-type="bibr">28</xref>, <xref rid="ref29" ref-type="bibr">29</xref>, <xref rid="ref32" ref-type="bibr">32)</xref>. Finally, i-tRFs are enriched within the internal regions of mature tRNAs, usually straddling the anticodon region (<xref rid="ref29" ref-type="bibr">29</xref>, <xref rid="ref33" ref-type="bibr">33)</xref>. It is important to highlight that in literature and in some databases, tsRNAs (which derive from 3′ trailer sequence of pre-tRNAs) are also termed tRF-1s (<xref rid="ref30" ref-type="bibr">30</xref>, <xref rid="ref34" ref-type="bibr">34</xref>, <xref rid="ref35" ref-type="bibr">35)</xref>.</p>
    <p>Additionally, a recently investigated group of tRFs, namely 5′ leader-exon tRFs, has been described in a study associating them with the loss of spinal motor neurons in CLP1-kinase dead mice (<xref rid="ref36" ref-type="bibr">36)</xref>. These fragments span from the beginning of the 5′ end of pre-tRNAs to the 5′ end of mature tRNAs and are produced inside the nucleus. However, their biogenesis and function remain still unknown, and consequently, this class has not currently been completely characterized (<xref rid="ref36" ref-type="bibr">36)</xref>.</p>
    <p>Our study aims at the identification of tRNA-derived ncRNAs in the National Cancer Institute 60 (NCI-60) cell lines and The Cancer Genome Atlas (TCGA) samples. This has been done through the development of a custom bioinformatics pipeline for the identification of tsRNAs (also termed tRF-1), tRFs (tRF-5s and tRF-3s) and 5′ leader RNAs in small non-coding RNA-seq (sncRNA-seq data).</p>
    <p>NCI-60 is a panel of 60 human cancer cell lines derived from nine different cancer types (leukemia, colon, lung, central nervous system, renal, melanoma, ovarian, breast and prostate) (<xref rid="ref37" ref-type="bibr">37–39)</xref>, while TCGA is a collection of samples covering 33 different tumor types with more than 11 000 cancer patients.</p>
    <p>We collected all the profiling results in an intuitive, publicly available database, tRFexplorer (<ext-link ext-link-type="uri" xlink:href="https://trfexplorer.cloud/">https://trfexplorer.cloud/</ext-link>). Our database allows users to search for tRNA-derived ncRNAs, visualize their expression profiles in both NCI-60 cell lines and TCGA patient cohorts, apply differential expression (DE) analysis on TCGA samples and correlate tRNA-derived ncRNA expression profiles with several covariates, such as NCI-60 omics data, TCGA mRNA and miRNA expressions, and TCGA patients survival data, in order to better aid in the identification of mechanisms in which such molecules might be involved in.</p>
  </sec>
  <sec id="sec2">
    <title>Material and methods</title>
    <sec id="sec3">
      <title>tRNA-derived ncRNAs identification pipeline</title>
      <p>The identification of tsRNAs, 5′ leader RNAs and tRFs in sncRNA-seq datasets is a complex process, since such small fragments may be mapped to multiple DNA regions. For this purpose, we implemented a conservative pipeline to get an accurate estimation of tsRNAs, 5′ leader RNAs and tRF expression. First, we assembled a custom annotation of the reference human genome (hg19) containing only known tsRNAs and tRFs. We included all tRF-5s, tRF-3s and tRF-1s from tRFdb (<ext-link ext-link-type="uri" xlink:href="http://genome.bioch.virginia.edu/trfdb/">http://genome.bioch.virginia.edu/trfdb/</ext-link>) (<xref rid="ref34" ref-type="bibr">34)</xref>, all tsRNA identified by (<xref rid="ref8" ref-type="bibr">8)</xref> and the 20-nt upstream region of tRNA human genes for the 5′ leader RNAs. Human tRNA genes were taken from GtRNAdb (<ext-link ext-link-type="uri" xlink:href="http://gtrnadb.ucsc.edu/">http://gtrnadb.ucsc.edu/</ext-link>) (<xref rid="ref40" ref-type="bibr">40)</xref>. Subsequently, we examined sncRNA-seq datasets of NCI-60 cell lines as provided by the sequence read archive (SRA) (PRJNA390643) (<xref rid="ref39" ref-type="bibr">39)</xref>, as well as sncRNA-seq datasets on TCGA. In <xref rid="TB1" ref-type="table">Table 1</xref>, we provide a list of NCI-60 cell lines and the SRA datasets, while in <xref rid="TB2" ref-type="table">Table 2</xref>, it lists the analyzed TCGA cancer types with their relative numbers of tumor and control samples. Raw FASTQ files were pre-processed for adaptor removal and quality filtering by applying Trim Galore (<ext-link ext-link-type="uri" xlink:href="https://www.bioinformatics.babraham.ac.uk/projects/trim_galore/">https://www.bioinformatics.babraham.ac.uk/projects/trim_galore/</ext-link>) tuned for sncRNA-seq (Phred quality score ≥20). Trim Galore is a wrapper for Cutadapt (<xref rid="ref41" ref-type="bibr">41)</xref> and FastQC (<ext-link ext-link-type="uri" xlink:href="http://www.bioinformatics.babraham.ac.uk/projects/fastqc/">http://www.bioinformatics.babraham.ac.uk/projects/fastqc/</ext-link>), which is used as a consistent method to apply quality filtering and adaptor trimming. Filtered FASTQ files were then aligned to a reference human genome (hg19) using TopHat version 2.1.0 (<xref rid="ref42" ref-type="bibr">42)</xref> as well as to our custom annotation file. Read quantification has been performed with HTSeq version 0.10.0 (<xref rid="ref43" ref-type="bibr">43)</xref>. In this phase, all ambiguously mapped reads were removed for a more accurate and conservative analysis. Data analysis was performed with R version 3.5.1. Raw counts were normalized with two different normalization methods: transcripts per million mapped reads (TPM) (<xref rid="ref44" ref-type="bibr">44)</xref> and reads per million mapped reads (RPM) (<xref rid="ref45" ref-type="bibr">45)</xref>.<disp-formula id="deqn01"><tex-math id="M1">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$ \mathrm{RPM}=\frac{\mathrm{number}\ \mathrm{of}\ \mathrm{reads}\ \mathrm{mapped}\ \mathrm{to}\ \mathrm{a}\ \mathrm{gene}\times {10}^6}{\mathrm{total}\ \mathrm{number}\ \mathrm{of}\ \mathrm{mapped}\ \mathrm{reads}\ \mathrm{for}\ \mathrm{a}\ \mathrm{given}\ \mathrm{library}} $$\end{document}</tex-math></disp-formula><disp-formula id="deqn02"><tex-math id="M2">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$ \begin{align*} \mathrm{TPM}&amp;=\frac{\mathrm{number}\ \mathrm{of}\ \mathrm{reads}\ \mathrm{mapped}\ \mathrm{to}\ \mathrm{a}\ \mathrm{gene}}{\mathrm{gene}\ \mathrm{length}\ \mathrm{in}\ \mathrm{bp}}\\ &amp;\quad \times \left(\frac{1}{\sum \frac{\mathrm{number}\ \mathrm{of}\ \mathrm{reads}\ \mathrm{mapped}\ \mathrm{to}\ \mathrm{a}\ \mathrm{gene}}{\mathrm{gene}\ \mathrm{length}\ \mathrm{in}\ \mathrm{bp}}}\right)\times {10}^6 \end{align*}$$\end{document}</tex-math></disp-formula></p>
      <table-wrap id="TB1" orientation="portrait" position="float">
        <label>Table 1</label>
        <caption>
          <p>List of NCI-60 cell lines tested and the relative SRA dataset</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="left" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th align="left" rowspan="1" colspan="1">Cell line</th>
              <th align="left" rowspan="1" colspan="1">Type of cancer</th>
              <th align="left" rowspan="1" colspan="1">SRA dataset</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">T-47D</td>
              <td align="left" rowspan="1" colspan="1">BREAST</td>
              <td align="left" rowspan="1" colspan="1">SRR5689215</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">MCF-7</td>
              <td align="left" rowspan="1" colspan="1">BREAST</td>
              <td align="left" rowspan="1" colspan="1">SRR5689213</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">MDA-MB-231</td>
              <td align="left" rowspan="1" colspan="1">BREAST</td>
              <td align="left" rowspan="1" colspan="1">SRR5689212</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">BT-549</td>
              <td align="left" rowspan="1" colspan="1">BREAST</td>
              <td align="left" rowspan="1" colspan="1">SRR5689211</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">HS-578T</td>
              <td align="left" rowspan="1" colspan="1">BREAST</td>
              <td align="left" rowspan="1" colspan="1">SRR5689210</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">SF-295</td>
              <td align="left" rowspan="1" colspan="1">CNS</td>
              <td align="left" rowspan="1" colspan="1">SRR5689217</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">SF-268</td>
              <td align="left" rowspan="1" colspan="1">CNS</td>
              <td align="left" rowspan="1" colspan="1">SRR5689216</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">SF-539</td>
              <td align="left" rowspan="1" colspan="1">CNS</td>
              <td align="left" rowspan="1" colspan="1">SRR5689214</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">U251</td>
              <td align="left" rowspan="1" colspan="1">CNS</td>
              <td align="left" rowspan="1" colspan="1">SRR5689209</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">SNB-75</td>
              <td align="left" rowspan="1" colspan="1">CNS</td>
              <td align="left" rowspan="1" colspan="1">SRR5689208</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">SNB-19</td>
              <td align="left" rowspan="1" colspan="1">CNS</td>
              <td align="left" rowspan="1" colspan="1">SRR5689175</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">HCT-116</td>
              <td align="left" rowspan="1" colspan="1">COLON</td>
              <td align="left" rowspan="1" colspan="1">SRR5689179</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">HT-29</td>
              <td align="left" rowspan="1" colspan="1">COLON</td>
              <td align="left" rowspan="1" colspan="1">SRR5689178</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">KM12</td>
              <td align="left" rowspan="1" colspan="1">COLON</td>
              <td align="left" rowspan="1" colspan="1">SRR5689177</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">SW-620</td>
              <td align="left" rowspan="1" colspan="1">COLON</td>
              <td align="left" rowspan="1" colspan="1">SRR5689176</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">COLO 205</td>
              <td align="left" rowspan="1" colspan="1">COLON</td>
              <td align="left" rowspan="1" colspan="1">SRR5689174</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">HCT-15</td>
              <td align="left" rowspan="1" colspan="1">COLON</td>
              <td align="left" rowspan="1" colspan="1">SRR5689173</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">HCC2998</td>
              <td align="left" rowspan="1" colspan="1">COLON</td>
              <td align="left" rowspan="1" colspan="1">SRR5689172</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">MOLT-4</td>
              <td align="left" rowspan="1" colspan="1">LEUKEMIA</td>
              <td align="left" rowspan="1" colspan="1">SRR5689193</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">K-562</td>
              <td align="left" rowspan="1" colspan="1">LEUKEMIA</td>
              <td align="left" rowspan="1" colspan="1">SRR5689192</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">SR</td>
              <td align="left" rowspan="1" colspan="1">LEUKEMIA</td>
              <td align="left" rowspan="1" colspan="1">SRR5689191</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">RPMI 8226</td>
              <td align="left" rowspan="1" colspan="1">LEUKEMIA</td>
              <td align="left" rowspan="1" colspan="1">SRR5689190</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">CCRF-CEM</td>
              <td align="left" rowspan="1" colspan="1">LEUKEMIA</td>
              <td align="left" rowspan="1" colspan="1">SRR5689183</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">HL-60(TB)</td>
              <td align="left" rowspan="1" colspan="1">LEUKEMIA</td>
              <td align="left" rowspan="1" colspan="1">SRR5689182</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">LOX-IMVI</td>
              <td align="left" rowspan="1" colspan="1">MELANOMA</td>
              <td align="left" rowspan="1" colspan="1">SRR5689197</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">MALME-3M</td>
              <td align="left" rowspan="1" colspan="1">MELANOMA</td>
              <td align="left" rowspan="1" colspan="1">SRR5689196</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">MDA-MB-435</td>
              <td align="left" rowspan="1" colspan="1">MELANOMA</td>
              <td align="left" rowspan="1" colspan="1">SRR5689195</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">M14</td>
              <td align="left" rowspan="1" colspan="1">MELANOMA</td>
              <td align="left" rowspan="1" colspan="1">SRR5689194</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">SK-MEL-5</td>
              <td align="left" rowspan="1" colspan="1">MELANOMA</td>
              <td align="left" rowspan="1" colspan="1">SRR5689189</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">SK-MEL-28</td>
              <td align="left" rowspan="1" colspan="1">MELANOMA</td>
              <td align="left" rowspan="1" colspan="1">SRR5689188</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">UACC-62</td>
              <td align="left" rowspan="1" colspan="1">MELANOMA</td>
              <td align="left" rowspan="1" colspan="1">SRR5689167</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">UACC-257</td>
              <td align="left" rowspan="1" colspan="1">MELANOMA</td>
              <td align="left" rowspan="1" colspan="1">SRR5689164</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">SK-MEL-2</td>
              <td align="left" rowspan="1" colspan="1">MELANOMA</td>
              <td align="left" rowspan="1" colspan="1">SRR5689165</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">NCI-H522</td>
              <td align="left" rowspan="1" colspan="1">NSCLC</td>
              <td align="left" rowspan="1" colspan="1">SRR5689201</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">NCI-H460</td>
              <td align="left" rowspan="1" colspan="1">NSCLC</td>
              <td align="left" rowspan="1" colspan="1">SRR5689200</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">HOP 62</td>
              <td align="left" rowspan="1" colspan="1">NSCLC</td>
              <td align="left" rowspan="1" colspan="1">SRR5689171</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">NCI-H23</td>
              <td align="left" rowspan="1" colspan="1">NSCLC</td>
              <td align="left" rowspan="1" colspan="1">SRR5689170</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">EKVX</td>
              <td align="left" rowspan="1" colspan="1">NSCLC</td>
              <td align="left" rowspan="1" colspan="1">SRR5689169</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">HOP 92</td>
              <td align="left" rowspan="1" colspan="1">NSCLC</td>
              <td align="left" rowspan="1" colspan="1">SRR5689168</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">A549</td>
              <td align="left" rowspan="1" colspan="1">NSCLC</td>
              <td align="left" rowspan="1" colspan="1">SRR5689166</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">NCI-H322M</td>
              <td align="left" rowspan="1" colspan="1">NSCLC</td>
              <td align="left" rowspan="1" colspan="1">SRR5689163</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">NCI-H226</td>
              <td align="left" rowspan="1" colspan="1">NSCLC</td>
              <td align="left" rowspan="1" colspan="1">SRR5689162</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">OVCAR-5</td>
              <td align="left" rowspan="1" colspan="1">OVARIAN</td>
              <td align="left" rowspan="1" colspan="1">SRR5689207</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">OVCAR-4</td>
              <td align="left" rowspan="1" colspan="1">OVARIAN</td>
              <td align="left" rowspan="1" colspan="1">SRR5689206</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">OVCAR-8</td>
              <td align="left" rowspan="1" colspan="1">OVARIAN</td>
              <td align="left" rowspan="1" colspan="1">SRR5689205</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">OVCAR-3</td>
              <td align="left" rowspan="1" colspan="1">OVARIAN</td>
              <td align="left" rowspan="1" colspan="1">SRR5689204</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">NCI/ADR-RES</td>
              <td align="left" rowspan="1" colspan="1">OVARIAN</td>
              <td align="left" rowspan="1" colspan="1">SRR5689203</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">IGR-OV1</td>
              <td align="left" rowspan="1" colspan="1">OVARIAN</td>
              <td align="left" rowspan="1" colspan="1">SRR5689202</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">SK-OV-3</td>
              <td align="left" rowspan="1" colspan="1">OVARIAN</td>
              <td align="left" rowspan="1" colspan="1">SRR5689198</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">DU-145</td>
              <td align="left" rowspan="1" colspan="1">PROSTATE</td>
              <td align="left" rowspan="1" colspan="1">SRR5689199</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">PC-3</td>
              <td align="left" rowspan="1" colspan="1">PROSTATE</td>
              <td align="left" rowspan="1" colspan="1">SRR5689187</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">A498</td>
              <td align="left" rowspan="1" colspan="1">RENAL</td>
              <td align="left" rowspan="1" colspan="1">SRR5689186</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">CAKI-1</td>
              <td align="left" rowspan="1" colspan="1">RENAL</td>
              <td align="left" rowspan="1" colspan="1">SRR5689185</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">786-0</td>
              <td align="left" rowspan="1" colspan="1">RENAL</td>
              <td align="left" rowspan="1" colspan="1">SRR5689184</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">SN12C</td>
              <td align="left" rowspan="1" colspan="1">RENAL</td>
              <td align="left" rowspan="1" colspan="1">SRR5689181</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">TK-10</td>
              <td align="left" rowspan="1" colspan="1">RENAL</td>
              <td align="left" rowspan="1" colspan="1">SRR5689180</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">UO-31</td>
              <td align="left" rowspan="1" colspan="1">RENAL</td>
              <td align="left" rowspan="1" colspan="1">SRR5689161</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">ACHN</td>
              <td align="left" rowspan="1" colspan="1">RENAL</td>
              <td align="left" rowspan="1" colspan="1">SRR5689160</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">RXF393</td>
              <td align="left" rowspan="1" colspan="1">RENAL</td>
              <td align="left" rowspan="1" colspan="1">SRR5689159</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <table-wrap id="TB2" orientation="portrait" position="float">
        <label>Table 2</label>
        <caption>
          <p>List of analyzed TCGA cancer types with their relative numbers of tumor and control samples</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th align="left" rowspan="1" colspan="1">Tumor type</th>
              <th align="left" rowspan="1" colspan="1">Tumor name</th>
              <th align="center" rowspan="1" colspan="1">Tumor samples</th>
              <th align="center" rowspan="1" colspan="1">Control samples</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">ACC</td>
              <td align="left" rowspan="1" colspan="1">Adrenocortical carcinoma</td>
              <td rowspan="1" colspan="1">79</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">BLCA</td>
              <td align="left" rowspan="1" colspan="1">Bladder urothelial carcinoma</td>
              <td rowspan="1" colspan="1">408</td>
              <td rowspan="1" colspan="1">19</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">BRCA</td>
              <td align="left" rowspan="1" colspan="1">Breast invasive carcinoma</td>
              <td rowspan="1" colspan="1">1101</td>
              <td rowspan="1" colspan="1">113</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">CESC</td>
              <td align="left" rowspan="1" colspan="1">Cervical squamous cell carcinoma and endocervical adenocarcinoma</td>
              <td rowspan="1" colspan="1">306</td>
              <td rowspan="1" colspan="1">3</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">CHOL</td>
              <td align="left" rowspan="1" colspan="1">Cholangiocarcinoma</td>
              <td rowspan="1" colspan="1">36</td>
              <td rowspan="1" colspan="1">9</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">COAD</td>
              <td align="left" rowspan="1" colspan="1">Colon adenocarcinoma</td>
              <td rowspan="1" colspan="1">459</td>
              <td rowspan="1" colspan="1">41</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">DLBC</td>
              <td align="left" rowspan="1" colspan="1">Lymphoid neoplasm diffuse large B-cell lymphoma</td>
              <td rowspan="1" colspan="1">48</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">ESCA</td>
              <td align="left" rowspan="1" colspan="1">Esophageal carcinoma</td>
              <td rowspan="1" colspan="1">185</td>
              <td rowspan="1" colspan="1">11</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">GBM</td>
              <td align="left" rowspan="1" colspan="1">Glioblastoma multiforme</td>
              <td rowspan="1" colspan="1">167</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">HNSC</td>
              <td align="left" rowspan="1" colspan="1">Head and neck squamous cell carcinoma</td>
              <td rowspan="1" colspan="1">522</td>
              <td rowspan="1" colspan="1">44</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">KICH</td>
              <td align="left" rowspan="1" colspan="1">Kidney chromophobe</td>
              <td rowspan="1" colspan="1">66</td>
              <td rowspan="1" colspan="1">25</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">KIRC</td>
              <td align="left" rowspan="1" colspan="1">Kidney renal clear cell carcinoma</td>
              <td rowspan="1" colspan="1">534</td>
              <td rowspan="1" colspan="1">72</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">KIRP</td>
              <td align="left" rowspan="1" colspan="1">Kidney renal papillary cell carcinoma</td>
              <td rowspan="1" colspan="1">291</td>
              <td rowspan="1" colspan="1">32</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">LAML</td>
              <td align="left" rowspan="1" colspan="1">Acute myeloid leukemia</td>
              <td rowspan="1" colspan="1">173</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">LGG</td>
              <td align="left" rowspan="1" colspan="1">Brain lower grade glioma</td>
              <td rowspan="1" colspan="1">533</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">LIHC</td>
              <td align="left" rowspan="1" colspan="1">Liver hepatocellular carcinoma</td>
              <td rowspan="1" colspan="1">374</td>
              <td rowspan="1" colspan="1">50</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">LUAD</td>
              <td align="left" rowspan="1" colspan="1">Lung adenocarcinoma</td>
              <td rowspan="1" colspan="1">517</td>
              <td rowspan="1" colspan="1">59</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">LUSC</td>
              <td align="left" rowspan="1" colspan="1">Lung squamous cell carcinoma</td>
              <td rowspan="1" colspan="1">501</td>
              <td rowspan="1" colspan="1">51</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">MESO</td>
              <td align="left" rowspan="1" colspan="1">Mesothelioma</td>
              <td rowspan="1" colspan="1">87</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">OV</td>
              <td align="left" rowspan="1" colspan="1">Ovarian serous cystadenocarcinoma</td>
              <td rowspan="1" colspan="1">309</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">PAAD</td>
              <td align="left" rowspan="1" colspan="1">Pancreatic adenocarcinoma</td>
              <td rowspan="1" colspan="1">179</td>
              <td rowspan="1" colspan="1">4</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">PCPG</td>
              <td align="left" rowspan="1" colspan="1">Pheochromocytoma and paraganglioma</td>
              <td rowspan="1" colspan="1">184</td>
              <td rowspan="1" colspan="1">3</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">PRAD</td>
              <td align="left" rowspan="1" colspan="1">Prostate adenocarcinoma</td>
              <td rowspan="1" colspan="1">498</td>
              <td rowspan="1" colspan="1">52</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">READ</td>
              <td align="left" rowspan="1" colspan="1">Rectum adenocarcinoma</td>
              <td rowspan="1" colspan="1">166</td>
              <td rowspan="1" colspan="1">10</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">SARC</td>
              <td align="left" rowspan="1" colspan="1">Sarcoma</td>
              <td rowspan="1" colspan="1">263</td>
              <td rowspan="1" colspan="1">2</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">SKCM</td>
              <td align="left" rowspan="1" colspan="1">Skin cutaneous melanoma</td>
              <td rowspan="1" colspan="1">472</td>
              <td rowspan="1" colspan="1">1</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">STAD</td>
              <td align="left" rowspan="1" colspan="1">Stomach adenocarcinoma</td>
              <td rowspan="1" colspan="1">414</td>
              <td rowspan="1" colspan="1">35</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">TGCT</td>
              <td align="left" rowspan="1" colspan="1">Testicular germ cell tumors</td>
              <td rowspan="1" colspan="1">139</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">THCA</td>
              <td align="left" rowspan="1" colspan="1">Thyroid carcinoma</td>
              <td rowspan="1" colspan="1">513</td>
              <td rowspan="1" colspan="1">59</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">THYM</td>
              <td align="left" rowspan="1" colspan="1">Thymoma</td>
              <td rowspan="1" colspan="1">120</td>
              <td rowspan="1" colspan="1">2</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">UCEC</td>
              <td align="left" rowspan="1" colspan="1">Uterine corpus endometrial carcinoma</td>
              <td rowspan="1" colspan="1">546</td>
              <td rowspan="1" colspan="1">23</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">UCS</td>
              <td align="left" rowspan="1" colspan="1">Uterine carcinosarcoma</td>
              <td rowspan="1" colspan="1">57</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">UVM</td>
              <td align="left" rowspan="1" colspan="1">Uveal melanoma</td>
              <td rowspan="1" colspan="1">80</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1">
                <bold>10 327</bold>
              </td>
              <td align="center" rowspan="1" colspan="1">
                <bold>720</bold>
              </td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>All tsRNAs, 5′ leader RNAs and tRFs with average log2 TPM less than 1 were removed. A summary of our full pipeline is shown in <xref rid="f1" ref-type="fig">Figure 1</xref>.</p>
      <fig id="f1" orientation="portrait" position="float">
        <label>Figure 1</label>
        <caption>
          <p>A summary of the tRNA-derived ncRNAs identification pipeline from RAW FASTQ files to normalized counts matrix.</p>
        </caption>
        <graphic xlink:href="baz115f1"/>
      </fig>
    </sec>
    <sec id="sec4">
      <title>Implementation of tRFexplorer
</title>
      <p>All identified tsRNAs, 5′ leader RNAs and tRFs with their expression profiles have been integrated in a novel database named tRFexplorer. tRFexplorer enables users to visualize the expression profile of each tRNA-derived ncRNA in both NCI-60 cell lines and TCGA samples (33 cancer types). Furthermore, it uses the R package limma (<xref rid="ref46" ref-type="bibr">46)</xref> to perform DE analysis on TCGA data. Interactive visualization of its results has been implemented through the R package Glimma (<xref rid="ref47" ref-type="bibr">47)</xref>. Our database allows users to conduct correlation analysis of tRNA-derived ncRNAs expression in NCI-60 with all data available on CellMiner (<xref rid="ref48" ref-type="bibr">48</xref>, <xref rid="ref49" ref-type="bibr">49)</xref>. Correlation analysis with genes and miRNA expression profiles, as well as patient survival, of TCGA samples has also been implemented.</p>
      <p>tRFexplorer was developed by employing PHP and R for its backend, and Javascript and React for the main user interface. All omics data and compound activities used for the correlation analysis were obtained from CellMiner (<xref rid="ref48" ref-type="bibr">48</xref>, <xref rid="ref49" ref-type="bibr">49)</xref>. In <xref rid="TB3" ref-type="table">Table 3</xref>, we list all CellMiner datasets.</p>
      <table-wrap id="TB3" orientation="portrait" position="float">
        <label>Table 3</label>
        <caption>
          <p>A list of CellMiner datasets with their description</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col align="left" span="1"/>
            <col align="left" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th align="left" rowspan="1" colspan="1">
                <bold>CellMiner dataset</bold>
              </th>
              <th align="left" rowspan="1" colspan="1">
                <bold>Description</bold>
              </th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">DNA CNV-Roche NibleGen 385 K aCGH</td>
              <td align="left" rowspan="1" colspan="1">385 K element tiling array based on NCBI Build 35 of the human genome (HG17) and re-mapped to NCBI Build 35 (HG19); 50-mer tiling with a median probe spacing of 6000 bp.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">DNA CNV-combined aCGH</td>
              <td align="left" rowspan="1" colspan="1">Probe intensities combined from four platforms: agilent human genome CGH Microarray 44A, Nimblegen HG19 CGH 385 K WG Tiling v2.0, Affymetrix GeneChip human mapping 500 k array set and Illumina Human1Mv1_C Beadchip</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">DNA single nucleotide polymorphism (SNP) per gene-Affy 500 K</td>
              <td align="left" rowspan="1" colspan="1">This platform is used for whole-genome association studies. It is comprised of two arrays which enable genotyping of more than 500 000 SNPs.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">DNA SNP per gene-Illumina 1 M SNP</td>
              <td align="left" rowspan="1" colspan="1">BeadChip array based on Illumina’s infinium assay with probes for 1 072 820 SNPs</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">DNA methylation-Illumina 450 K</td>
              <td align="left" rowspan="1" colspan="1">Approximately 450 000 probes querying the methylation status of CpG sites within and outside of genes.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">RNA Affy HG-U133_AB</td>
              <td align="left" rowspan="1" colspan="1">Human genome U133. 44 000 probeset 2-chip set. Gene expression.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">RNA Affy HG-U133 Plus 2.0</td>
              <td align="left" rowspan="1" colspan="1">Aproximately 47 000 transcripts</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">RNA Affy HuEx 1.0</td>
              <td align="left" rowspan="1" colspan="1">1 432 155 probesets for all human gene exons</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">RNA agilent human mRNAs</td>
              <td align="left" rowspan="1" colspan="1">44 000 probes for approximately 41 000 genes, with four arrays spotted on each slide.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">RNA expression combined z-scores</td>
              <td align="left" rowspan="1" colspan="1">Gene expressions</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">RNA agilent human miRNAs</td>
              <td align="left" rowspan="1" colspan="1">15 000 probes for 723 human and 76 human viral miRNA’s. Each slide contains eight arrays.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">RNA microRNA OSU V3 Chip</td>
              <td align="left" rowspan="1" colspan="1">Custom microarray developed at Microarray Shared Resource Comprehensive Cancer Center, OSU microarray facility. It contains 11 k probes (two technical replicates) for murin and human microRNAs together with hypothetical microRNAs and control probes.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">RNA ABC transporters array</td>
              <td align="left" rowspan="1" colspan="1">47 specific oligonucleotide probes were designed for each of the ABC transporters using DNAStar Primer Select. Expression levels were measured by real-time quantitative RT-PCR using the LightCycler RNA Amplification SYBR Green kit and a LightCycler machine.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">RNA OSU transporter array</td>
              <td align="left" rowspan="1" colspan="1">Spotted 70-mer microarray</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Protein lysate array</td>
              <td align="left" rowspan="1" colspan="1">Reverse-phase lysate arrays (RPLA) for 162 antibodies for 94 genes. Each array included 64 lysates (60 cancer cells and 4 replicate control pools) in 10 serial 2-fold dilutions.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Compound activities</td>
              <td align="left" rowspan="1" colspan="1">Negative log10 (GI50) values of sulforhodamine B assay for ~ 50 K compounds, including more than 20 000 that passed quality control, 158 Food and Drug Administration approved and 79 clinical trial drugs. Higher values equate to higher sensitivity of cell lines.</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>Genomic viewer for tRNA-derived ncRNAs visualization is based on JBrowse (<xref rid="ref50" ref-type="bibr">50)</xref>. JBrowse is a fast and interactive genomic viewer built entirely with new HTML5 technology. We customized our browser by allowing users to search for both tRNAs or tRNA-derived ncRNAs using both genomic coordinates or identifiers.</p>
    </sec>
  </sec>
  <sec id="sec5">
    <title>Results</title>
    <sec id="sec6">
      <title>tRNA-derived ncRNAs identified
</title>
      <p>In our study, we employed NCI-60 (<xref rid="ref39" ref-type="bibr">39)</xref> and TCGA sncRNA-seq datasets to identify tsRNAs, 5′ leader RNAs and tRFs, assessing their expression profile. In these datasets, we were able to identify 322 expressed tRNA-derived ncRNAs in NCI-60 (11 tRF-5s, 55 tRF-3s, 107 tsRNAs and 149 5′ leader RNAs) and 232 expressed tRNA-derived ncRNAs (53 tRF-5s, 58 tRF-3s, 63 tsRNAs and 58 5′ leader RNAs) in TCGA. A number of tsRNAs, 5′ leader RNAs and tRFs identified across NCI-60 cell lines and TCGA samples present noticeable expression levels. Moreover, all small RNA sequences mapped within four specific regions: 5′ end (tRF-5) and 3′ end (tRF-3) of mature tRNA, and 3′ trailer (tsRNA or tRF-1) and 5′ leader (5′ leader RNAs) regions of primary tRNA genes. If these small RNA sequences were the result of a random degradation process, their ends would be equally distributed along the lengths of tRNA genes with a comparable frequency (<xref rid="ref34" ref-type="bibr">34</xref>, <xref rid="ref35" ref-type="bibr">35)</xref>. In addition, we can observe that each TCGA cancer type (whose control samples are available) displays a different pattern of dysregulated tRNA-derived ncRNAs. Taken together, these results may suggest that these small RNAs are not fragments derived from the random cleavage of precursor and mature tRNAs, rather they are actively expressed and produced by specific ribonucleases and may be dysregulated in several human cancers. Indeed, recent evidences have shown dysregulated tRNA-derived ncRNAs in Chronic lymphocytic leukemia (CLL), colon, breast, ovary, lung and prostate cancers (<xref rid="ref8" ref-type="bibr">8</xref>, <xref rid="ref9" ref-type="bibr">9</xref>, <xref rid="ref11" ref-type="bibr">11</xref>, <xref rid="ref12" ref-type="bibr">12</xref>, <xref rid="ref51" ref-type="bibr">51</xref>, <xref rid="ref52" ref-type="bibr">52)</xref>.</p>
    </sec>
    <sec id="sec7">
      <title>tRFexplorer database</title>
      <p>All identified sncRNAs have been integrated in a novel database named tRFexplorer. tRFexplorer is an easy-to-use, web-based database (<ext-link ext-link-type="uri" xlink:href="https://trfexplorer.cloud/">https://trfexplorer.cloud/</ext-link>) containing tRNA-derived ncRNAs expression profiles for NCI-60 cell lines and TCGA samples, together with all omics and compound activities data available on CellMiner (<xref rid="TB3" ref-type="table">Table 3</xref>). Leveraging CellMiner data, tRFexplorer enables users to perform correlation analysis inferring knowledge on the biological function of such molecules. Furthermore, a module allowing DE analysis for all tRNA-derived ncRNAs in TCGA samples has been released. A detailed explanation of tRFexplorer functions is provided in the following sections.</p>
      <p><italic>Browse.</italic> In the ‘Browse’ section, users can search for tsRNAs, 5′ leader RNAs and tRFs by ‘location’ or ‘expression’. Browsing by location enables users to search and visualize all tRNA-derived ncRNAs in the reference human genome (<xref rid="f2" ref-type="fig">Figure 2</xref>). Specifically, through the custom genome browser, it is possible to interactively search tRNA-derived ncRNAs either by genomic coordinates or by identifier.</p>
      <fig id="f2" orientation="portrait" position="float">
        <label>Figure 2</label>
        <caption>
          <p>The genomic location of ts-106 visualized in our interactive genome viewer.</p>
        </caption>
        <graphic xlink:href="baz115f2"/>
      </fig>
      <p>Browsing by expression section enables users to filter data using at least one of the following options: (i) the type of fragment (tRF-3, tRF-5, tsRNA and 5′ leader RNAs); (ii) the amino acid carried by the pre-tRNA; (iii) the anticodon sequence; (iv) the dataset in which the fragment is expressed (TCGA tumor types or NCI-60 cell lines); and (v) the tissue subtype (normal, tumor, metastatic, recurrent, etc). It is also possible to set a minimum RPM threshold for tRNA-derived ncRNAs. The search procedure will scan our database looking for all tRNA-derived ncRNAs matching users criteria, and the results will be reported in a table.</p>
      <p>Once results become available, users may view a page with detailed information by selecting any single result. Such page will show plots for assessing RPM expression levels in both NCI-60 (<xref rid="f3" ref-type="fig">Figure 3</xref>) and TCGA (<xref rid="f4" ref-type="fig">Figure 4</xref>). A genomic viewer will show genomic locations for each tRNA-derived fragment.</p>
      <fig id="f3" orientation="portrait" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Example of bar plot which shows tRFdb-3022a expression across NCI-60 cell line.</p>
        </caption>
        <graphic xlink:href="baz115f3"/>
      </fig>
      <fig id="f4" orientation="portrait" position="float">
        <label>Figure 4</label>
        <caption>
          <p>Example of box plot which shows tRFdb-3022a expression across TCGA cancer types.</p>
        </caption>
        <graphic xlink:href="baz115f4"/>
      </fig>
      <p><italic>Correlation analysis.</italic> In the ‘Correlation Analysis’ section, users can perform correlation analyses of all identified tsRNAs, 5′ leader RNAs and tRFs in NCI-60, with the omics and compound activities data available on CellMiner (<xref rid="ref48" ref-type="bibr">48)</xref> (<xref rid="TB3" ref-type="table">Table 3</xref>). Correlation analysis can also be performed with mRNA/miRNA expression profiles, as well as patient survival data, of TCGA samples. Specifically, the user selects the correlation measure (Pearson or Spearman) and which dataset to consider. A list of correlated and anticorrelated tRNA-derived ncRNAs will be shown. The results can then be filtered by: (i) ncRNA name; (ii) genes, miRNAs, compound names; (iii) the genomic coordinates, when available; and (iv) the minimum correlation value. By clicking on each result, an interactive scatter plot with the data of the selected molecules will appear (<xref rid="f5" ref-type="fig">Figure 5</xref>).</p>
      <fig id="f5" orientation="portrait" position="float">
        <label>Figure 5</label>
        <caption>
          <p>Example of a scatter plot which shows the correlation between the expression profile of ts-62 in NCI-60 and the expression of NOTCH4.</p>
        </caption>
        <graphic xlink:href="baz115f5"/>
      </fig>
      <p><italic>DE analysis.</italic> In the ‘DE analysis’ section, users can perform DE analysis to discover which tsRNAs, 5′ leader RNAs and tRFs are dysregulated in TCGA tumor types. To start the analysis, users select the cancer type and one of the available covariates (gender, race, vital status, sample type or classification). It is also possible to set the maximum <italic>P</italic>-value and minimum log-fold-change (logFC) for the analysis. After selecting all the parameters, users must select at least one contrast to perform for the DE analysis, in association with the selected covariate. Once the analysis is launched, a list of differentially expressed tRNA-derived ncRNAs with their logFC and FDR adjusted <italic>P</italic>-value will be shown together with an interactive volcano plot to better visualize their DE (<xref rid="f6" ref-type="fig">Figure 6</xref>). By clicking on a specific point in the plot or row in the table, a swarm plot of the expression values will also be shown (<xref rid="f6" ref-type="fig">Figure 6</xref>).</p>
      <fig id="f6" orientation="portrait" position="float">
        <label>Figure 6</label>
        <caption>
          <p>Vulcano plot which shows the differentially expressed tRNA-derived ncRNAs in TCGA Lung Squamous Cell Carcinoma (LUSC) when compared with control samples, and a swarm plot which specifically shows the difference in the expression profile of one (tRFdb-5015a) of the differentially expressed tRNA-derived ncRNAs.</p>
        </caption>
        <graphic xlink:href="baz115f6"/>
      </fig>
    </sec>
    <sec id="sec8">
      <title>Comparison between tRFexplorer and MINTbase V.2.0</title>
      <p>We compared data and features of tRFexplorer with MINTbase V2.0 (<xref rid="ref53" ref-type="bibr">53)</xref>, another established database of tRNA-derived ncRNAs in TCGA. MINTbase V2.0 has a user-friendly graphical user interface and it combines data from 768 different human datasets and 11.198 TCGA small RNA-Seq datasets. MINTbase V2.0, however, is focused only on tRFs, i-tRF and tiRNAs (or tRNA halves). Indeed, only tRNA-derived ncRNAs formed from mature tRNAs are taken into account. tsRNAs and 5′ leader RNAs, coming from pre-tRNAs, are not available in MINTbase V.2.0. On the other hand, tRFexplorer does not store tiRNAs and i-tRF. <xref rid="TB4" ref-type="table">Table 4</xref> reports the tRNA-derived ncRNAs classes stored in tRFexplorer and MINTbase V.2.0, respectively.</p>
      <p>Concerning tRNA-derived ncRNAs identification methods, we aim to stress an important difference between tRFexplorer and MINTbase. The tRFs available in MINTbase V2.0 have been identified with MINTmap (<xref rid="ref54" ref-type="bibr">54)</xref> prediction algorithm. Instead, tRFexplorer uses well-known mapping and counting tools (see Materials and Methods 2.1) to identify the RNA reads mapping on our custom annotated human genome. Specifically, we used the genomic coordinates obtained from tRFdb (<xref rid="ref34" ref-type="bibr">34)</xref> for the identification of tRF-5s and tRF-3s and the genomic coordinates published on (<xref rid="ref8" ref-type="bibr">8)</xref> for the identification of the experimental validated tsRNAs. Finally, for the 5′ leader RNAs identification, we counted the RNA reads mapped on the 20-nt upstream regions of all human tRNA genes. We used this strategy since tRFdb nomenclature is the most widely used for tRFs in literature while we used the genomic coordinates present on (<xref rid="ref8" ref-type="bibr">8)</xref> for tsRNAs since they were identified by <italic>in vitro</italic> experiments and not with in-silico prediction.</p>
      <p>Moreover, one of the aims of our work was to report only high confident tRFs and 5′ leader RNAs and <italic>in vitro</italic> validated tsRNAs. Specifically, we reported 399 tRNA-derived ncRNAs on tRFexplorer (some of them are expressed both on NCI-60 and TCGA datasets, while others are specifically expressed either on NCI-60 or TCGA datasets). On the contrary, a very large number of unique sequences reported on MINTbase V.2.0 (28.824) were identified through the prediction algorithm MINTmap. We noticed that many tRFs, i-tRFs and tiRNAs reported in MINTbase V.2.0 are expressed with 1 RPM in a single dataset (1 out of 12.023). Specifically, 6.248 out of 28.824 unique sequences present on MINTbase V.2.0 are expressed in only one dataset (1 out of 12.023), while 15.717 out of 28.824 unique sequences are expressed in only 10 out of 12.023 datasets. It is also well established that tRF-5s and tRF-3s have well-defined length and they can be further stratified in tRF-5a (14–16 nts), tRF-5b (22–24 nts), tRF-5c (28–30 nts), tRF-3a (about 18 nts) and tRF-3b (about 22 nts) subclasses accordingly to their size (<xref rid="ref13" ref-type="bibr">13</xref>, <xref rid="ref15" ref-type="bibr">15</xref>, <xref rid="ref30" ref-type="bibr">30</xref>, <xref rid="ref32" ref-type="bibr">32)</xref>. Moreover, tRF-5s and tRF-3s are produced by ribonuclease cleavage in the D-loop and T-loop region, respectively (<xref rid="ref13" ref-type="bibr">13</xref>, <xref rid="ref15" ref-type="bibr">15</xref>, <xref rid="ref30" ref-type="bibr">30</xref>, <xref rid="ref32" ref-type="bibr">32)</xref>. In MINTbase V2.0, we noticed that 252 out of 2304 tRF-5s and 1439 out of 4028 tRF-3s are longer than 31 and 25 nt, respectively, while 248 out of 2304 tRF-5s and 284 out of 4028 tRF-3s have sequences that do not end at their cleavage site in the D-loop or T-loop, respectively, but they overlap the anticodon region.</p>
      <table-wrap id="TB4" orientation="portrait" position="float">
        <label>Table 4</label>
        <caption>
          <p>tRNA-derived ncRNAs classes stored in tRFexplorer and MINTbase V2.0</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col align="left" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th rowspan="1" colspan="1"/>
              <th align="center" rowspan="1" colspan="1">tRFexplorer</th>
              <th align="center" rowspan="1" colspan="1">MINTbase V.2.0</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">5′ Leader RNAs</td>
              <td align="center" rowspan="1" colspan="1">x</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">tsRNAs</td>
              <td align="center" rowspan="1" colspan="1">x</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">tRF (tRF-5s and tRF-3s)</td>
              <td align="center" rowspan="1" colspan="1">x</td>
              <td align="center" rowspan="1" colspan="1">x</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">tiRNAs (tiRNA-5s and tiRNA-3s)</td>
              <td rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1">x</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">i-tRF</td>
              <td rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1">x</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>Indeed, the total number of tRNAs-derived ncRNAs in MINTbase V2.0 looks quite high if we consider that in the human genome, there are only about 400 tRNA genes and that many 5′ and 3′ end regions of mature tRNAs are shared across different tRNAs, and therefore, a single tRFs, with the same sequence, can be produced by different tRNAs. For this reason, to avoid overestimation, we decided to keep very low the number of identified tRNA-derived ncRNAs.</p>
      <p>Finally, we conducted a comparison between the features of tRFexplorer vs those available in MINTbase V.2.0. tRFexplorer implements several specific functions such as: explore the genomic location of tRNA-derived ncRNAs through an interactive genomic browser; perform DE analysis in all TCGA samples; and finally correlation analysis with different TCGA (mRNAs and miRNAs expression) and CellMiner (omics data and compounds activities) data. Moreover, different high-quality plots are available on tRFexplorer to better understand the results. A detailed comparison of the features is shown in <xref rid="TB5" ref-type="table">Table 5</xref>.</p>
      <table-wrap id="TB5" orientation="portrait" position="float">
        <label>Table 5</label>
        <caption>
          <p>Features comparison of tRFexplorer and MINTbase V2.0</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="left" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th rowspan="1" colspan="1"/>
              <th align="left" rowspan="1" colspan="1">tRFexplorer</th>
              <th align="left" rowspan="1" colspan="1">MINTbase V.2.0</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">Datasets</td>
              <td align="left" rowspan="1" colspan="1">TCGA, NCI-60</td>
              <td align="left" rowspan="1" colspan="1">TCGA, human datasets</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Total number datasets</td>
              <td align="left" rowspan="1" colspan="1">12.187 + 59 = 12.246</td>
              <td align="left" rowspan="1" colspan="1">12.023</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">tRNA-derived ncRNAs identification methods</td>
              <td align="left" rowspan="1" colspan="1">Mapping and counting on custom annotated human genome</td>
              <td align="left" rowspan="1" colspan="1">Prediction based on MINTmap</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">tRNA-derived ncRNAs filtering expression criteria</td>
              <td align="left" rowspan="1" colspan="1">Mean Log2 TPM &gt; 1 across all samples</td>
              <td align="left" rowspan="1" colspan="1">RPM ≥ 1 in a single sample</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Unique sequences</td>
              <td align="left" rowspan="1" colspan="1">399</td>
              <td align="left" rowspan="1" colspan="1">28.824</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">tRFs sub-classification according to their size</td>
              <td align="left" rowspan="1" colspan="1">Available</td>
              <td align="left" rowspan="1" colspan="1">Not available</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Normalization methods</td>
              <td align="left" rowspan="1" colspan="1">TPM, RPM</td>
              <td align="left" rowspan="1" colspan="1">RPM</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Interactive genomic browser</td>
              <td align="left" rowspan="1" colspan="1">Available</td>
              <td align="left" rowspan="1" colspan="1">Not available</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">DE analysis</td>
              <td align="left" rowspan="1" colspan="1">Available</td>
              <td align="left" rowspan="1" colspan="1">Not available</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Correlation analysis</td>
              <td align="left" rowspan="1" colspan="1">Available</td>
              <td align="left" rowspan="1" colspan="1">Not available</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Plot for data visualization</td>
              <td align="left" rowspan="1" colspan="1">Bar plot, box plot, scatter plot, volcano plot, swarm plot</td>
              <td align="left" rowspan="1" colspan="1">Bar plot, box plot</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Other data for tRNA-derived ncRNAs correlation analysis</td>
              <td align="left" rowspan="1" colspan="1">TCGA mRNAs and miRNAs expression, CellMiner datasets</td>
              <td align="left" rowspan="1" colspan="1">No other data available</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </sec>
  </sec>
  <sec id="sec9">
    <title>Discussion</title>
    <p>Our study aims at identifying tsRNAs, 5′ leader RNAs and tRFs in NCI-60 and TCGA small RNA-seq datasets, together with an intuitive web interface for data querying and browsing. For this purpose, we implemented a custom bioinformatics pipeline for the detection and quantification of these ncRNAs from small RNA-Seq data. Due to TCGA’s large sample base, we took into consideration NCI-60 in light of its extensive use for the testing of novel compounds and the identification of drug-response biomarkers (<xref rid="ref55" ref-type="bibr">55–60)</xref>. We analyzed recent versions of the NCI-60 (<xref rid="ref39" ref-type="bibr">39)</xref> and TCGA small RNA-seq datasets to identify and establish expression profiles for tsRNAs, 5′ leader RNAs and tRFs. In these datasets, we were able to detect 322 expressed tRNA-derived ncRNAs in NCI-60 (11 tRF-5s, 55 tRF-3s, 107 tsRNAs and 149 5′ leader RNAs) and 232 expressed tRNA-derived ncRNAs in TCGA samples (53 tRF-5s, 58 tRF-3s, 63 tsRNAs and 58 5′ leader RNAs). Our reference tsRNA and tRF annotation were obtained from (<xref rid="ref8" ref-type="bibr">8)</xref> and tRFdb (<xref rid="ref34" ref-type="bibr">34)</xref>, respectively. 5′ leader RNAs were obtained from the 20-nt upstream region of tRNA genes and named by using the tRNA identifier from which they derived.</p>
    <p>It is noteworthy that the high expression levels of some tsRNAs, 5′ leader RNAs and tRFs in both NCI-60 and TCGA, and their DEs across TCGA cancer types indicate that these molecules are not fragments derived from the random cleavage of precursor and mature tRNAs, suggesting that such molecules may be actively expressed and produced by specific ribonucleases. Indeed, if tsRNAs, 5′ leader RNAs and tRFs were the results of a random degradation process, their ends would be equally distributed along the lengths of tRNA genes with a comparable frequency (<xref rid="ref34" ref-type="bibr">34</xref>, <xref rid="ref35" ref-type="bibr">35)</xref>. In our case, small RNA sequences mapped on four specific regions: 5′ end (tRF-5) and 3′ end (tRF-3) of mature tRNA, and 3′ trailer (tsRNA or tRF-1) and 5′ leader (5′ leader RNAs) regions of primary tRNA genes. Pre-tRNA molecules undergo a maturation process inside the nucleus, where 5′ leader and 3′ trailer sequences are cleaved by RNAse P and RNAse Z, respectively (<xref rid="ref15" ref-type="bibr">15)</xref>. It is established that tsRNAs are derived from the 3′ trailer region of pre-tRNAs (<xref rid="ref9" ref-type="bibr">9)</xref>. Conversely, the identification of small RNA sequencing reads mapping within the pre-tRNA 5′ leader genomic region represents an additional evidence of this yet poorly investigated class of tsRNAs (<xref rid="ref24" ref-type="bibr">24</xref>, <xref rid="ref25" ref-type="bibr">25</xref>, <xref rid="ref61" ref-type="bibr">61)</xref>. Although some authors already reported tRNA fragments mapping between 5′ leader region and mature tRNA (<xref rid="ref36" ref-type="bibr">36</xref>, <xref rid="ref62" ref-type="bibr">62)</xref>, our 5′ sequences are entirely located inside the pre-tRNA leader region. Furthermore, such sequences extend up to the RNAse P cleavage site, without going beyond such site. The high expression of 5′ leader RNAs and their specific ends in correspondence of RNAse P cutting site supports the hypothesis that these molecules could have a biological function, although an <italic>in vitro</italic> validation is still missing.</p>
    <p>All identified tsRNAs, 5′ leader RNAs and tRFs have been stored in tRFexplorer, a novel database accessible through an easy-to-use web interface. tRFexplorer allows us to visualize the expression profile of each tsRNAs, 5′ leader RNAs and tRFs for all NCI-60 cell lines and TCGA tumor types. Furthermore, it enables DE analysis for all tumor types present in TCGA and correlation analysis with all omics and compounds activity data reported on CellMiner. The interface is comprised of three main sections: ‘Browse’; ‘DE Analysis’; and ‘Correlation Analysis’. The ‘Browse’ section is used to search tsRNAs, 5′ leader RNAs and tRFs by location and expression. For each sncRNA, its expression is displayed in both NCI-60 cell lines and TCGA tumor types. Moreover, an interactive genomic viewer allows users to search and visualize all the identified tRNA-derived ncRNAs in the reference human genome. Through the DE analysis panel, users can discover which tRNA-derived ncRNAs are dysregulated in each TCGA tumor type. By selecting the cancer type to analyze and one of their variables (gender, race, vital status, sample type or classification), together with the <italic>P</italic>-value threshold and minimum logFC, a list of differentially expressed tRNA-derived ncRNAs with their logFC and FDR adjusted <italic>P</italic>-value will be shown. Volcano plots and swarm plots are also shown in order to better elucidate their DE. Finally, through the ‘Correlation Analysis’ panel, the user can perform correlation analyses of all identified tRNA-derived ncRNAs in NCI-60 with the omics and compound activities data available on CellMiner (<xref rid="ref48" ref-type="bibr">48)</xref> (<xref rid="TB3" ref-type="table">Table 3</xref>). In addition, correlation analysis with genes, miRNA expression and patients’ survival data of TCGA samples are also possible. The correlation tool will yield only the molecules that have an absolute correlation coefficient greater than 0.5. The user also has the option to select two different correlation measures (Pearson and Spearman).</p>
    <p>The correlation analysis aids in the investigation of the biological function of tRNA-derived ncRNAs, as there is currently poor evidence in such regard. For this purpose, their correlation or anticorrelation with protein levels, mRNA and miRNA expressions, could provide a first clue regarding a potential biological pathway in which these ncRNAs may be involved.</p>
    <p>Moreover, tRNA-derived ncRNAs showing high correlations or anticorrelations with the activity profiles (chemoresistance and chemosensitivity) of a specific antitumor compound could be selected for further studies as drug response biomarkers. Indeed, in a recent study, it has been shown that some tRFs are dysregulated in cell lines of breast cancer resistant to Trastuzumab against sensitive cell lines (<xref rid="ref63" ref-type="bibr">63)</xref>.</p>
    <p>Finally, we compared data and features of tRFexplorer with MINTbase V2.0 (<xref rid="ref53" ref-type="bibr">53)</xref>, a database of tRNA-derived ncRNAs in TCGA. From the comparison, we can establish that, to avoid overestimation and artifacts within the databases, tRFexplorer stores less tRNA-derived ncRNAs with respect to MINTbase. On the other hand, tRFexplorer presents a more flexible interface allowing rich functional data analysis.</p>
  </sec>
  <sec id="sec10">
    <title>Conclusion</title>
    <p>This study introduces a novel database called tRFexplorer equipped with a Web App enabling the exploration of tRNA-derived ncRNAs expression profiles (tsRNAs, 5′ leader pre-tRNAs derived small RNAs, and tRFs) on the NCI-60 panel and TCGA samples. By exploiting DE analysis, tRFexplorer allows users to study the specific pattern of dysregulated tRNA-derived ncRNAs of each TCGA cancer type. Finally, a correlation analysis tool provided by our software may be employed as an instrument to investigate the putative biological roles of these molecules in the absence of direct experimental validation of their functions while allowing users to consider further <italic>in vitro</italic> and <italic>in vivo</italic> investigations on the most promising molecules.</p>
  </sec>
  <sec id="sec11">
    <title>Availability</title>
    <p>tRFexplorer is available at <ext-link ext-link-type="uri" xlink:href="https://trfexplorer.cloud/">https://trfexplorer.cloud/</ext-link>.</p>
  </sec>
</body>
<back>
  <ack id="baz115-ack">
    <title>Acknowledgements</title>
    <p>The results presented in this manuscript are in part based upon data generated by the TCGA Research Network: <ext-link ext-link-type="uri" xlink:href="http://cancergenome.nih.gov/">http://cancergenome.nih.gov/</ext-link> (Project #19459 - tsRNA signature in Cancer - Consent #73394-2).</p>
  </ack>
  <sec id="sec12">
    <title>Funding</title>
    <p>A.L.F. is supported by the PhD fellowship on Complex Systems for Physical, Socio-economic and Life Sciences funded by the Italian MIUR ‘PON RI FSE-FESR 2014-2020’. S.A., A.F. and A.P. have been partially supported by the research project ‘Marcatori molecolari e clinico-strumentali precoci, nelle patologie metaboliche e cronico-degenerative’ founded by the Department of Clinical and Experimental Medicine of the University of Catania. S.A., A.F. and A.P. have also been partially supported by the MIUR PON research project BILIGeCT ‘Liquid Biopsies for Cancer Clinical Management’. A.P. has also been partially supported by the Italian MIUR FFABR grant.</p>
    <p><italic>Conflict of interest</italic>. The authors declare that they have no conflict of interests.</p>
  </sec>
  <ref-list id="bib1">
    <title>REFERENCES</title>
    <ref id="ref1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Veneziano</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Nigita</surname><given-names>G.</given-names></name> and <name name-style="western"><surname>Ferro</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>) <article-title>Computational approaches for the analysis of ncRNA through deep sequencing techniques</article-title>. <source>Front. Bioeng. Biotechnol.</source>, <volume>3</volume>, <fpage>77</fpage>.<pub-id pub-id-type="pmid">26090362</pub-id></mixed-citation>
    </ref>
    <ref id="ref2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saleembhasha</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Mishra</surname><given-names>S.</given-names></name></person-group> (<year>2018</year>) <article-title>Novel molecules lncRNAs, tRFs and circRNAs deciphered from next-generation sequencing/RNA sequencing: computational databases and tools</article-title>. <source>Briefings Funct. Genomics</source>, <volume>17</volume>, <fpage>15</fpage>–<lpage>25</lpage>.</mixed-citation>
    </ref>
    <ref id="ref3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Veneziano</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Di Bella</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Nigita</surname><given-names>G.</given-names></name><etal>et al.</etal></person-group> (<year>2016</year>) <article-title>Noncoding RNA: current deep sequencing data analysis approaches and challenges</article-title>. <source>Hum. Mutat.</source>, <volume>37</volume>, <fpage>1283</fpage>–<lpage>1298</lpage>.<pub-id pub-id-type="pmid">27516218</pub-id></mixed-citation>
    </ref>
    <ref id="ref4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>H.K.</given-names></name>, <name name-style="western"><surname>Fuchs</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>S.</given-names></name><etal>et al.</etal></person-group> (<year>2017</year>) <article-title>A transfer-RNA-derived small RNA regulates ribosome biogenesis</article-title>. <source>Nature</source>, <volume>552</volume>, <fpage>57</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="pmid">29186115</pub-id></mixed-citation>
    </ref>
    <ref id="ref5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schorn</surname><given-names>A.J.</given-names></name>, <name name-style="western"><surname>Gutbrod</surname><given-names>M.J.</given-names></name>, <name name-style="western"><surname>LeBlanc</surname><given-names>C.</given-names></name><etal>et al.</etal></person-group> (<year>2017</year>) <article-title>LTR-retrotransposon control by tRNA-derived small RNAs</article-title>. <source>Cell</source>, <volume>170</volume>, <fpage>61</fpage>–<lpage>71.e11</lpage>.<pub-id pub-id-type="pmid">28666125</pub-id></mixed-citation>
    </ref>
    <ref id="ref6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ivanov</surname><given-names>P.</given-names></name></person-group> (<year>2015</year>) <article-title>Emerging roles of tRNA-derived fragments in viral infections: the case of respiratory syncytial virus. Emerging roles of tRNA-derived fragments in viral infections: the case of respiratory syncytial virus</article-title>. <source>Mol. Ther.</source>, <volume>23</volume>, <fpage>1557</fpage>–<lpage>1558</lpage>.<pub-id pub-id-type="pmid">26442802</pub-id></mixed-citation>
    </ref>
    <ref id="ref7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saikia</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Jobava</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Parisien</surname><given-names>M.</given-names></name><etal>et al.</etal></person-group> (<year>2014</year>) <article-title>Angiogenin-cleaved tRNA halves interact with cytochrome c, protecting cells from apoptosis during osmotic stress</article-title>. <source>Mol. Cell. Biol.</source>, <volume>34</volume>, <fpage>2450</fpage>–<lpage>2463</lpage>.<pub-id pub-id-type="pmid">24752898</pub-id></mixed-citation>
    </ref>
    <ref id="ref8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Balatti</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Nigita</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Veneziano</surname><given-names>D.</given-names></name><etal>et al.</etal></person-group> (<year>2017</year>) <article-title>tsRNA signatures in cancer</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>, <volume>114</volume>, <fpage>8071</fpage>–<lpage>8076</lpage>.<pub-id pub-id-type="pmid">28696308</pub-id></mixed-citation>
    </ref>
    <ref id="ref9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pekarsky</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Balatti</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Palamarchuk</surname><given-names>A.</given-names></name><etal>et al.</etal></person-group> (<year>2016</year>) <article-title>Dysregulation of a family of short noncoding RNAs, tsRNAs, in human cancer</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>, <volume>113</volume>, <fpage>5071</fpage>–<lpage>5076</lpage>.<pub-id pub-id-type="pmid">27071132</pub-id></mixed-citation>
    </ref>
    <ref id="ref10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Slack</surname><given-names>F.J.</given-names></name></person-group> (<year>2018</year>) <article-title>Tackling tumors with small RNAs derived from transfer RNA</article-title>. <source>N. Engl. J. Med.</source>, <volume>378</volume>, <fpage>1842</fpage>–<lpage>1843</lpage>.<pub-id pub-id-type="pmid">29742367</pub-id></mixed-citation>
    </ref>
    <ref id="ref11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>X.</given-names></name><etal>et al.</etal></person-group> (<year>2017</year>) <article-title>tRF/miR-1280 suppresses stem cell-like cells and metastasis in colorectal cancer</article-title>. <source>Cancer Res.</source>, <volume>77</volume>, <fpage>3194</fpage>–<lpage>3206</lpage>.<pub-id pub-id-type="pmid">28446464</pub-id></mixed-citation>
    </ref>
    <ref id="ref12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shao</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name><etal>et al.</etal></person-group> (<year>2017</year>) <article-title>tRF-Leu-CAG promotes cell proliferation and cell cycle in non-small cell lung cancer</article-title>. <source>Chem. Biol. Drug Des.</source>, <volume>90</volume>, <fpage>730</fpage>–<lpage>738</lpage>.<pub-id pub-id-type="pmid">28378898</pub-id></mixed-citation>
    </ref>
    <ref id="ref13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Balatti</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Pekarsky</surname><given-names>Y.</given-names></name> and <name name-style="western"><surname>Croce</surname><given-names>C.M.</given-names></name></person-group> (<year>2017</year>) <article-title>Role of the tRNA-derived small RNAs in cancer: new potential biomarkers and target for therapy</article-title>. <source>Adv. Cancer Res.</source>, <volume>135</volume>, <fpage>173</fpage>–<lpage>187</lpage>.<pub-id pub-id-type="pmid">28882222</pub-id></mixed-citation>
    </ref>
    <ref id="ref14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuscu</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Kumar</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Kiran</surname><given-names>M.</given-names></name><etal>et al.</etal></person-group> (<year>2018</year>) <article-title>tRNA fragments (tRFs) guide ago to regulate gene expression post-transcriptionally in a dicer-independent manner</article-title>. <source>RNA</source>, <volume>24</volume>, <fpage>1093</fpage>–<lpage>1105</lpage>.<pub-id pub-id-type="pmid">29844106</pub-id></mixed-citation>
    </ref>
    <ref id="ref15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>Z.</given-names></name> and <name name-style="western"><surname>Sheng</surname><given-names>J.</given-names></name></person-group> (<year>2018</year>) <article-title>tRNA-derived small RNA: a novel regulatory small non-coding RNA</article-title>. <source>Genes</source>, <volume>9</volume>, <fpage>E246</fpage>.<pub-id pub-id-type="pmid">29748504</pub-id></mixed-citation>
    </ref>
    <ref id="ref16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Tolkach</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Schmidt</surname><given-names>D.</given-names></name><etal>et al.</etal></person-group> (<year>2018</year>) <article-title>5′-tRNA halves are dysregulated in clear cell renal cell carcinoma</article-title>. <source>J. Urol.</source>, <volume>199</volume>, <fpage>378</fpage>–<lpage>383</lpage>.<pub-id pub-id-type="pmid">28765068</pub-id></mixed-citation>
    </ref>
    <ref id="ref17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yeri</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Courtright</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Reiman</surname><given-names>R.</given-names></name><etal>et al.</etal></person-group> (<year>2017</year>) <article-title>Total extracellular small RNA profiles from plasma, saliva, and urine of healthy subjects</article-title>. <source>Sci. Rep.</source>, <volume>7</volume>, <comment>44061</comment>.</mixed-citation>
    </ref>
    <ref id="ref18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dhahbi</surname><given-names>J.M.</given-names></name>, <name name-style="western"><surname>Spindler</surname><given-names>S.R.</given-names></name>, <name name-style="western"><surname>Atamna</surname><given-names>H.</given-names></name><etal>et al.</etal></person-group> (<year>2014</year>) <article-title>Deep sequencing of serum small RNAs identifies patterns of 5′ tRNA half and YRNA fragment expression associated with breast cancer</article-title>. <source>Biomark. Cancer</source>, <volume>6</volume>, <comment>BIC.S20764</comment>.</mixed-citation>
    </ref>
    <ref id="ref19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Godoy</surname><given-names>P.M.</given-names></name>, <name name-style="western"><surname>Bhakta</surname><given-names>N.R.</given-names></name>, <name name-style="western"><surname>Barczak</surname><given-names>A.J.</given-names></name><etal>et al.</etal></person-group> (<year>2018</year>) <article-title>Large differences in small RNA composition between human biofluids</article-title>. <source>Cell Rep.</source>, <volume>25</volume>, <fpage>1346</fpage>–<lpage>1358</lpage>.<pub-id pub-id-type="pmid">30380423</pub-id></mixed-citation>
    </ref>
    <ref id="ref20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walczyk</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Gößringer</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Rossmanith</surname><given-names>W.</given-names></name><etal>et al.</etal></person-group> (<year>2016</year>) <article-title>Analysis of the cleavage mechanism by protein-only RNase P using precursor tRNA substrates with modifications at the cleavage site</article-title>. <source>J. Mol. Biol.</source>, <volume>428</volume>, <fpage>4917</fpage>–<lpage>4928</lpage>.<pub-id pub-id-type="pmid">27769719</pub-id></mixed-citation>
    </ref>
    <ref id="ref21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brillante</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Gößringer</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Lindenhofer</surname><given-names>D.</given-names></name><etal>et al.</etal></person-group> (<year>2016</year>) <article-title>Substrate recognition and cleavage-site selection by a single-subunit protein-only RNase P</article-title>. <source>Nucleic Acids Res.</source>, <volume>44</volume>, <fpage>2323</fpage>–<lpage>2336</lpage>.<pub-id pub-id-type="pmid">26896801</pub-id></mixed-citation>
    </ref>
    <ref id="ref22">
      <label>22.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Simos</surname><given-names>G.</given-names></name> and <name name-style="western"><surname>Hurt</surname><given-names>E.</given-names></name></person-group> (<year>1999</year>) <article-title>Transfer RNA biogenesis: a visa to leave the nucleus</article-title>. <source>Curr. Biol.</source>, <volume>9</volume>, <fpage>R238</fpage>–<lpage>R241</lpage>.<pub-id pub-id-type="pmid">10209112</pub-id></mixed-citation>
    </ref>
    <ref id="ref23">
      <label>23.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>Y.S.</given-names></name>, <name name-style="western"><surname>Shibata</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Malhotra</surname><given-names>A.</given-names></name><etal>et al.</etal></person-group> (<year>2009</year>) <article-title>A novel class of small RNAs: tRNA-derived RNA fragments (tRFs)</article-title>. <source>Genes Dev.</source>, <volume>23</volume>, <fpage>2639</fpage>–<lpage>2649</lpage>.<pub-id pub-id-type="pmid">19933153</pub-id></mixed-citation>
    </ref>
    <ref id="ref24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leung</surname><given-names>Y.Y.</given-names></name>, <name name-style="western"><surname>Kuksa</surname><given-names>P.P.</given-names></name>, <name name-style="western"><surname>Amlie-Wolf</surname><given-names>A.</given-names></name><etal>et al.</etal></person-group> (<year>2016</year>) <article-title>DASHR: database of small human noncoding RNAs</article-title>. <source>Nucleic Acids Res.</source>, <volume>44</volume>, <fpage>D216</fpage>–<lpage>D222</lpage>.<pub-id pub-id-type="pmid">26553799</pub-id></mixed-citation>
    </ref>
    <ref id="ref25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chung</surname><given-names>I.-F.</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>S.-J.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>C.-Y.</given-names></name><etal>et al.</etal></person-group> (<year>2017</year>) <article-title>YM500v3: a database for small RNA sequencing in human cancer research</article-title>. <source>Nucleic Acids Res.</source>, <volume>45</volume>, <fpage>D925</fpage>–<lpage>D931</lpage>.<pub-id pub-id-type="pmid">27899625</pub-id></mixed-citation>
    </ref>
    <ref id="ref26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fu</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Q.</given-names></name><etal>et al.</etal></person-group> (<year>2009</year>) <article-title>Stress induces tRNA cleavage by angiogenin in mammalian cells</article-title>. <source>FEBS Lett.</source>, <volume>583</volume>, <fpage>437</fpage>–<lpage>442</lpage>.<pub-id pub-id-type="pmid">19114040</pub-id></mixed-citation>
    </ref>
    <ref id="ref27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thompson</surname><given-names>D.M.</given-names></name> and <name name-style="western"><surname>Parker</surname><given-names>R.</given-names></name></person-group> (<year>2009</year>) <article-title>The RNase Rny1p cleaves tRNAs and promotes cell death during oxidative stress in Saccharomyces cerevisiae</article-title>. <source>J. Cell Biol.</source>, <volume>185</volume>, <fpage>43</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="pmid">19332891</pub-id></mixed-citation>
    </ref>
    <ref id="ref28">
      <label>28.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Anaya</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Mudunuri</surname><given-names>S.B.</given-names></name><etal>et al.</etal></person-group> (<year>2014</year>) <article-title>Meta-analysis of tRNA derived RNA fragments reveals that they are evolutionarily conserved and associate with AGO proteins to recognize specific RNA targets</article-title>. <source>BMC Biol.</source>, <volume>12</volume>, <fpage>78</fpage>.<pub-id pub-id-type="pmid">25270025</pub-id></mixed-citation>
    </ref>
    <ref id="ref29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>W.-L.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y.-D.</given-names></name><etal>et al.</etal></person-group> (<year>2017</year>) <article-title>Computational approaches to tRNA-derived small RNAs</article-title>. <source>Noncoding RNA</source>, <volume>3</volume>, <fpage>E2</fpage>.<pub-id pub-id-type="pmid">29657274</pub-id></mixed-citation>
    </ref>
    <ref id="ref30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shen</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>L.</given-names></name><etal>et al.</etal></person-group> (<year>2018</year>) <article-title>Transfer RNA-derived fragments and tRNA halves: biogenesis, biological functions and their roles in diseases</article-title>. <source>J. Mol. Med.</source>, <volume>96</volume>, <fpage>1167</fpage>–<lpage>1176</lpage>.<pub-id pub-id-type="pmid">30232504</pub-id></mixed-citation>
    </ref>
    <ref id="ref31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cole</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Sobala</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>C.</given-names></name><etal>et al.</etal></person-group> (<year>2009</year>) <article-title>Filtering of deep sequencing data reveals the existence of abundant dicer-dependent small RNAs derived from tRNAs</article-title>. <source>RNA</source>, <volume>15</volume>, <fpage>2147</fpage>–<lpage>2160</lpage>.<pub-id pub-id-type="pmid">19850906</pub-id></mixed-citation>
    </ref>
    <ref id="ref32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Kuscu</surname><given-names>C.</given-names></name> and <name name-style="western"><surname>Dutta</surname><given-names>A.</given-names></name></person-group> (<year>2016</year>) <article-title>Biogenesis and function of transfer RNA-related fragments (tRFs)</article-title>. <source>Trends Biochem. Sci.</source>, <volume>41</volume>, <fpage>679</fpage>–<lpage>689</lpage>.<pub-id pub-id-type="pmid">27263052</pub-id></mixed-citation>
    </ref>
    <ref id="ref33">
      <label>33.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Telonis</surname><given-names>A.G.</given-names></name>, <name name-style="western"><surname>Loher</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Honda</surname><given-names>S.</given-names></name><etal>et al.</etal></person-group> (<year>2015</year>) <article-title>Dissecting tRNA-derived fragment complexities using personalized transcriptomes reveals novel fragment classes and unexpected dependencies</article-title>. <source>Oncotarget</source>, <volume>6</volume>, <fpage>24797</fpage>–<lpage>24822</lpage>.<pub-id pub-id-type="pmid">26325506</pub-id></mixed-citation>
    </ref>
    <ref id="ref34">
      <label>34.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Mudunuri</surname><given-names>S.B.</given-names></name>, <name name-style="western"><surname>Anaya</surname><given-names>J.</given-names></name><etal>et al.</etal></person-group> (<year>2015</year>) <article-title>tRFdb: a database for transfer RNA fragments</article-title>. <source>Nucleic Acids Res.</source>, <volume>43</volume>, <fpage>D141</fpage>–<lpage>D145</lpage>.<pub-id pub-id-type="pmid">25392422</pub-id></mixed-citation>
    </ref>
    <ref id="ref35">
      <label>35.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>L.-L.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>W.-L.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>S.</given-names></name><etal>et al.</etal></person-group> (<year>2016</year>) <article-title>tRF2Cancer: A web server to detect tRNA-derived small RNA fragments (tRFs) and their expression in multiple cancers</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>44</volume>, <fpage>W185</fpage>–<lpage>W193</lpage>.<pub-id pub-id-type="pmid">27179031</pub-id></mixed-citation>
    </ref>
    <ref id="ref36">
      <label>36.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hanada</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Weitzer</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Mair</surname><given-names>B.</given-names></name><etal>et al.</etal></person-group> (<year>2013</year>) <article-title>CLP1 links tRNA metabolism to progressive motor-neuron loss</article-title>. <source>Nature</source>, <volume>495</volume>, <fpage>474</fpage>–<lpage>480</lpage>.<pub-id pub-id-type="pmid">23474986</pub-id></mixed-citation>
    </ref>
    <ref id="ref37">
      <label>37.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shoemaker</surname><given-names>R.H.</given-names></name></person-group> (<year>2006</year>) <article-title>The NCI60 human tumour cell line anticancer drug screen</article-title>. <source>Nat. Rev. Cancer</source>, <volume>6</volume>, <fpage>813</fpage>–<lpage>823</lpage>.<pub-id pub-id-type="pmid">16990858</pub-id></mixed-citation>
    </ref>
    <ref id="ref38">
      <label>38.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Niu</surname><given-names>N.</given-names></name> and <name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name></person-group> (<year>2015</year>) <article-title>In vitro human cell line models to predict clinical response to anticancer drugs</article-title>. <source>Pharmacogenomics</source>, <volume>16</volume>, <fpage>273</fpage>–<lpage>285</lpage>.<pub-id pub-id-type="pmid">25712190</pub-id></mixed-citation>
    </ref>
    <ref id="ref39">
      <label>39.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marshall</surname><given-names>E.A.</given-names></name>, <name name-style="western"><surname>Sage</surname><given-names>A.P.</given-names></name>, <name name-style="western"><surname>Ng</surname><given-names>K.W.</given-names></name><etal>et al.</etal></person-group> (<year>2017</year>) <article-title>Small non-coding RNA transcriptome of the NCI-60 cell line panel</article-title>. <source>Sci. Data</source>, <volume>4</volume>, <fpage>170157</fpage>.<pub-id pub-id-type="pmid">29064465</pub-id></mixed-citation>
    </ref>
    <ref id="ref40">
      <label>40.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>P.P.</given-names></name> and <name name-style="western"><surname>Lowe</surname><given-names>T.M.</given-names></name></person-group> (<year>2016</year>) <article-title>GtRNAdb 2.0: an expanded database of transfer RNA genes identified in complete and draft genomes</article-title>. <source>Nucleic Acids Res.</source>, <volume>44</volume>, <fpage>D184</fpage>–<lpage>D189</lpage>.<pub-id pub-id-type="pmid">26673694</pub-id></mixed-citation>
    </ref>
    <ref id="ref41">
      <label>41.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martin</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>) <article-title>Cutadapt removes adapter sequences from high-throughput sequencing reads</article-title>. <source>EMBnet.j</source>, <volume>17</volume>, <fpage>10</fpage>–<lpage>12</lpage>.</mixed-citation>
    </ref>
    <ref id="ref42">
      <label>42.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Pertea</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Trapnell</surname><given-names>C.</given-names></name><etal>et al.</etal></person-group> (<year>2013</year>) <article-title>TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions</article-title>. <source>Genome Biol.</source>, <volume>14</volume>, <fpage>R36</fpage>.<pub-id pub-id-type="pmid">23618408</pub-id></mixed-citation>
    </ref>
    <ref id="ref43">
      <label>43.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anders</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Pyl</surname><given-names>P.T.</given-names></name> and <name name-style="western"><surname>Huber</surname><given-names>W.</given-names></name></person-group> (<year>2015</year>) <article-title>HTSeq—a python framework to work with high-throughput sequencing data</article-title>. <source>Bioinformatics</source>, <volume>31</volume>, <fpage>166</fpage>–<lpage>169</lpage>.<pub-id pub-id-type="pmid">25260700</pub-id></mixed-citation>
    </ref>
    <ref id="ref44">
      <label>44.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wagner</surname><given-names>G.P.</given-names></name>, <name name-style="western"><surname>Kin</surname><given-names>K.</given-names></name> and <name name-style="western"><surname>Lynch</surname><given-names>V.J.</given-names></name></person-group> (<year>2012</year>) <article-title>Measurement of mRNA abundance using RNA-seq data: RPKM measure is inconsistent among samples</article-title>. <source>Theory Biosci.</source>, <volume>131</volume>, <fpage>281</fpage>–<lpage>285</lpage>.<pub-id pub-id-type="pmid">22872506</pub-id></mixed-citation>
    </ref>
    <ref id="ref45">
      <label>45.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mortazavi</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>B.A.</given-names></name>, <name name-style="western"><surname>McCue</surname><given-names>K.</given-names></name><etal>et al.</etal></person-group> (<year>2008</year>) <article-title>Mapping and quantifying mammalian transcriptomes by RNA-Seq</article-title>. <source>Nat. Methods</source>, <volume>5</volume>, <fpage>621</fpage>–<lpage>628</lpage>.<pub-id pub-id-type="pmid">18516045</pub-id></mixed-citation>
    </ref>
    <ref id="ref46">
      <label>46.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ritchie</surname><given-names>M.E.</given-names></name>, <name name-style="western"><surname>Phipson</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>D.</given-names></name><etal>et al.</etal></person-group> (<year>2015</year>) <article-title>Limma powers differential expression analyses for RNA-sequencing and microarray studies</article-title>. <source>Nucleic Acids Res.</source>, <volume>43</volume>, <fpage>e47</fpage>.<pub-id pub-id-type="pmid">25605792</pub-id></mixed-citation>
    </ref>
    <ref id="ref47">
      <label>47.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Su</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Law</surname><given-names>C.W.</given-names></name>, <name name-style="western"><surname>Ah-Cann</surname><given-names>C.</given-names></name><etal>et al.</etal></person-group> (<year>2017</year>) <article-title>Glimma: interactive graphics for gene expression analysis</article-title>. <source>Bioinformatics</source>, <volume>33</volume>, <fpage>2050</fpage>–<lpage>2052</lpage>.<pub-id pub-id-type="pmid">28203714</pub-id></mixed-citation>
    </ref>
    <ref id="ref48">
      <label>48.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reinhold</surname><given-names>W.C.</given-names></name>, <name name-style="western"><surname>Sunshine</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>H.</given-names></name><etal>et al.</etal></person-group> (<year>2012</year>) <article-title>CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set</article-title>. <source>Cancer Res.</source>, <volume>72</volume>, <fpage>3499</fpage>–<lpage>3511</lpage>.<pub-id pub-id-type="pmid">22802077</pub-id></mixed-citation>
    </ref>
    <ref id="ref49">
      <label>49.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reinhold</surname><given-names>W.C.</given-names></name>, <name name-style="western"><surname>Sunshine</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Varma</surname><given-names>S.</given-names></name><etal>et al.</etal></person-group> (<year>2015</year>) <article-title>Using CellMiner 1.6 for systems pharmacology and genomic analysis of the NCI-60</article-title>. <source>Clin. Cancer Res.</source>, <volume>21</volume>, <fpage>3841</fpage>–<lpage>3852</lpage>.<pub-id pub-id-type="pmid">26048278</pub-id></mixed-citation>
    </ref>
    <ref id="ref50">
      <label>50.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Buels</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Yao</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Diesh</surname><given-names>C.M.</given-names></name><etal>et al.</etal></person-group> (<year>2016</year>) <article-title>JBrowse: a dynamic web platform for genome visualization and analysis</article-title>. <source>Genome Biol.</source>, <volume>17</volume>, <fpage>66</fpage>.<pub-id pub-id-type="pmid">27072794</pub-id></mixed-citation>
    </ref>
    <ref id="ref51">
      <label>51.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feng</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Chu</surname><given-names>J.</given-names></name><etal>et al.</etal></person-group> (<year>2018</year>) <article-title>Identification of tRNA-derived small noncoding RNAs as potential biomarkers for prediction of recurrence in triple-negative breast cancer. Identification of tRNA-derived small noncoding RNAs as potential biomarkers for prediction of recurrence in triple-negative breast cancer</article-title>. <source><italic toggle="yes">Cancer Med.</italic></source>, <volume>7</volume>, <fpage>5130</fpage>–<lpage>5144</lpage>.<pub-id pub-id-type="pmid">30239174</pub-id></mixed-citation>
    </ref>
    <ref id="ref52">
      <label>52.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olvedy</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Scaravilli</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Hoogstrate</surname><given-names>Y.</given-names></name><etal>et al.</etal></person-group> (<year>2016</year>) <article-title>A comprehensive repertoire of tRNA-derived fragments in prostate cancer</article-title>. <source>Oncotarget</source>, <volume>7</volume>, <fpage>24766</fpage>–<lpage>24777</lpage>.<pub-id pub-id-type="pmid">27015120</pub-id></mixed-citation>
    </ref>
    <ref id="ref53">
      <label>53.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pliatsika</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Loher</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Magee</surname><given-names>R.</given-names></name><etal>et al.</etal></person-group> (<year>2018</year>) <article-title>MINTbase v2.0: a comprehensive database for tRNA-derived fragments that includes nuclear and mitochondrial fragments from all the cancer genome atlas projects</article-title>. <source>Nucleic Acids Res.</source>, <volume>46</volume>, <fpage>D152</fpage>–<lpage>D159</lpage>.<pub-id pub-id-type="pmid">29186503</pub-id></mixed-citation>
    </ref>
    <ref id="ref54">
      <label>54.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Loher</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Telonis</surname><given-names>A.G.</given-names></name> and <name name-style="western"><surname>Rigoutsos</surname><given-names>I.</given-names></name></person-group> (<year>2017</year>) <article-title>MINTmap: fast and exhaustive profiling of nuclear and mitochondrial tRNA fragments from short RNA-seq data</article-title>. <source>Sci. Rep.</source>, <volume>7</volume>, <fpage>41184</fpage>.<pub-id pub-id-type="pmid">28220888</pub-id></mixed-citation>
    </ref>
    <ref id="ref55">
      <label>55.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raghu</surname><given-names>V.K.</given-names></name>, <name name-style="western"><surname>Beckwitt</surname><given-names>C.H.</given-names></name>, <name name-style="western"><surname>Warita</surname><given-names>K.</given-names></name><etal>et al.</etal></person-group> (<year>2018</year>) <article-title>Biomarker identification for statin sensitivity of cancer cell lines</article-title>. <source>Biochem. Biophys. Res. Commun.</source>, <volume>495</volume>, <fpage>659</fpage>–<lpage>665</lpage>.<pub-id pub-id-type="pmid">29146185</pub-id></mixed-citation>
    </ref>
    <ref id="ref56">
      <label>56.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gholami</surname><given-names>A.M.</given-names></name>, <name name-style="western"><surname>Hahne</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>Z.</given-names></name><etal>et al.</etal></person-group> (<year>2013</year>) <article-title>Global proteome analysis of the NCI-60 cell line panel</article-title>. <source>Cell Rep.</source>, <volume>4</volume>, <fpage>609</fpage>–<lpage>620</lpage>.<pub-id pub-id-type="pmid">23933261</pub-id></mixed-citation>
    </ref>
    <ref id="ref57">
      <label>57.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blower</surname><given-names>P.E.</given-names></name>, <name name-style="western"><surname>Chung</surname><given-names>J.-H.</given-names></name>, <name name-style="western"><surname>Verducci</surname><given-names>J.S.</given-names></name><etal>et al.</etal></person-group> (<year>2008</year>) <article-title>MicroRNAs modulate the chemosensitivity of tumor cells</article-title>. <source>Mol. Cancer Ther.</source>, <volume>7</volume>, <fpage>1</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">18187804</pub-id></mixed-citation>
    </ref>
    <ref id="ref58">
      <label>58.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Jaarsveld</surname><given-names>M.T.M.</given-names></name>, <name name-style="western"><surname>Helleman</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Boersma</surname><given-names>A.W.M.</given-names></name><etal>et al.</etal></person-group> (<year>2013</year>) <article-title>miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells</article-title>. <source>Oncogene</source>, <volume>32</volume>, <fpage>4284</fpage>–<lpage>4293</lpage>.<pub-id pub-id-type="pmid">23045278</pub-id></mixed-citation>
    </ref>
    <ref id="ref59">
      <label>59.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>D.S.</given-names></name></person-group> (<year>2014</year>) <article-title>Novel prediction of anticancer drug chemosensitivity in cancer cell lines: evidence of moderation by microRNA expressions</article-title>. <source>Conf. Proc. IEEE Eng. Med. Biol. Soc.</source>, <volume>2014</volume>, <fpage>4780</fpage>–<lpage>4786</lpage>.<pub-id pub-id-type="pmid">25571061</pub-id></mixed-citation>
    </ref>
    <ref id="ref60">
      <label>60.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name> and <name name-style="western"><surname>Mansmann</surname><given-names>U.R.</given-names></name></person-group> (<year>2015</year>) <article-title>A microRNA molecular modeling extension for prediction of colorectal cancer treatment</article-title>. <source>BMC Cancer</source>, <volume>15</volume>, <fpage>472</fpage>.<pub-id pub-id-type="pmid">26084510</pub-id></mixed-citation>
    </ref>
    <ref id="ref61">
      <label>61.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuksa</surname><given-names>P.P.</given-names></name>, <name name-style="western"><surname>Amlie-Wolf</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Katanic</surname><given-names>Z.</given-names></name><etal>et al.</etal></person-group> (<year>2018</year>) <article-title>DASHR 2.0: integrated database of human small non-coding RNA genes and mature products</article-title>. <source>Bioinformatics</source>, <volume>1</volume>, <fpage>7</fpage>.</mixed-citation>
    </ref>
    <ref id="ref62">
      <label>62.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>P.</given-names></name> and <name name-style="western"><surname>Ivanov</surname><given-names>P.</given-names></name></person-group> (<year>2014</year>) <article-title>tRNA fragments in human health and disease</article-title>. <source>FEBS Lett.</source>, <volume>588</volume>, <fpage>4297</fpage>–<lpage>4304</lpage>.<pub-id pub-id-type="pmid">25220675</pub-id></mixed-citation>
    </ref>
    <ref id="ref63">
      <label>63.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><etal>et al.</etal></person-group> (<year>2018</year>) <article-title>tRNA-derived fragments as novel predictive biomarkers for Trastuzumab-resistant breast cancer</article-title>. <source>Cell. Physiol. Biochem.</source>, <volume>49</volume>, <fpage>419</fpage>–<lpage>431</lpage>.<pub-id pub-id-type="pmid">30153663</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
